BioLineRx Ltd. (BLRX)
NASDAQ: BLRX · Real-Time Price · USD
3.850
-0.060 (-1.53%)
At close: Oct 13, 2025, 4:00 PM EDT
3.840
-0.010 (-0.26%)
After-hours: Oct 13, 2025, 5:30 PM EDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of $17.47 million as of October 13, 2025. Its market cap has decreased by -67.83% in one year.
Market Cap
17.47M
Enterprise Value
1.53M
1-Year Change
-67.83%
Ranking
Category
Stock Price
$3.85
Market Cap Chart
Since July 27, 2009, BioLineRx's market cap has decreased from $33.80M to $17.47M, a decrease of -48.31%. That is a compound annual growth rate of -3.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2025 | 17.47M | -25.61% |
| Dec 31, 2024 | 23.49M | -79.62% |
| Dec 31, 2023 | 115.26M | 305.33% |
| Dec 29, 2022 | 28.44M | -71.41% |
| Dec 30, 2021 | 99.46M | 66.19% |
| Dec 31, 2020 | 59.85M | 124.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |